title: Belonging to a peer support group enhance the quality of life and adherence rate in patients affected by breast cancer: A non-randomized controlled clinical trial.
abstract: BACKGROUND
  Breast cancer is the most common cancer in women. It seems that breast cancer patients benefit from meeting someone who had a similar experience. This study evaluated the effect of two kinds of interventions (peer support and educational program) on quality of life in breast cancer patients.
  
  
  METHODS
  This study was a controlled clinical trial on women with non-metastatic breast cancer. The patients studied in two experimental and control groups. Experimental group took part in peer support program and control group passed a routine educational program during 3 months. The authors administered SF-36 for evaluating the quality of life pre-and post intervention. Also, patient's adherence was assessed by means of a simple checklist.
  
  
  RESULTS
  Two groups were similar with respect of age, age of onset of the disease, duration of having breast cancer, marital status, type of the treatment receiving now, and type of the received surgery. In the control group, there were statistically significant improvements in body pain, role-physical, role-emotional and social functioning. In experimental group, role-physical, vitality, social functioning, role-emotional and mental health showed significant improvement. Vitality score and mental health score in experimental group was significantly higher than that of the control group, both with p < 0.001. Also, it was shown that adherence was in high levels in both groups and no significant difference was seen after the study was done.
  
  
  CONCLUSIONS
  According to the results of this study, supporting the patients with breast cancer by forming peer groups or by means of educational sessions could improve their life qualities.
authors.affiliation: Resident of Community Medicine, Department of Community Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Afsaneh Malekpour
authors.initials: AM
authors.lastname: Tehrani
authors.forename: Ziba
authors.initials: Z
authors.lastname: Farajzadegan
authors.forename: Fariborz Mokarian
authors.initials: FM
authors.lastname: Rajabi
authors.forename: Ahmad Reza
authors.initials: AR
authors.lastname: Zamani
references.citation: Health Psychol. 2004 Mar;23(2):207-18
references.pmid: 15008666
references.citation: N Engl J Med. 2001 Dec 13;345(24):1719-26
references.pmid: 11742045
references.citation: J Clin Oncol. 2005 Sep 1;23(25):6009-18
references.pmid: 16135469
references.citation: AIDS Patient Care STDS. 2002 Feb;16(2):83-96
references.pmid: 11874640
references.citation: Arch Gen Psychiatry. 1999 Apr;56(4):340-7
references.pmid: 10197829
references.citation: Qual Life Res. 2005 Apr;14(3):875-82
references.pmid: 16022079
references.citation: Patient Educ Couns. 2004 Oct;55(1):3-15
references.pmid: 15476984
references.citation: Patient Educ Couns. 2004 May;53(2):141-6
references.pmid: 15140453
references.citation: Support Care Cancer. 2003 Dec;11(12):763-8
references.pmid: 14564493
references.citation: Psychooncology. 2002 May-Jun;11(3):199-211
references.pmid: 12112480
references.citation: Patient Educ Couns. 2005 Oct;59(1):1-12
references.pmid: 16198213
references.citation: Health Qual Life Outcomes. 2010 Jul 23;8:74
references.pmid: 20653966
references.citation: Health Psychol. 2000 Mar;19(2):107-14
references.pmid: 10762094
references.citation: Eur J Cancer. 2006 Sep;42(14):2271-6
references.pmid: 16644208
references.citation: N Engl J Med. 2005 Aug 4;353(5):487-97
references.pmid: 16079372